The forthcoming targeted agent, such as menin inhibitory, can also cause DS, characterized by symptoms like fever, arthralgias, leukocytosis, pleural or pericardial effusions, and respiratory or renal failure in severe cases [25,55,56,57,58,59,60,61]. The gene discussed is MEN1; the disease is Dravet syndrome.